https://scholars.lib.ntu.edu.tw/handle/123456789/161547
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 臺大醫院-腫瘤醫學部;臺大醫學院-腫瘤醫學研究所;臺大醫學院-癌症研究中心; | - |
dc.contributor.author | Yang, James Chih-Hsin | en |
dc.contributor.author | Popat, Sanjay | en |
dc.contributor.author | Georgiou, Panos | en |
dc.contributor.author | Miyamoto, Emiko | en |
dc.contributor.author | Isaacson, Jeffrey D. | en |
dc.contributor.author | Wakelee, Heather A. | en |
dc.creator | Yang, James Chih-Hsin;Popat, Sanjay;Georgiou, Panos;Miyamoto, Emiko;Isaacson, Jeffrey D.;Wakelee, Heather A. | en |
dc.creator | 楊志新 | zh-tw |
dc.date | 2015 | - |
dc.date.accessioned | 2017-06-27T08:34:43Z | - |
dc.date.accessioned | 2018-07-09T02:45:38Z | - |
dc.date.available | 2017-06-27T08:34:43Z | - |
dc.date.available | 2018-07-09T02:45:38Z | - |
dc.date.issued | 2015 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/280106 | - |
dc.language | en-us | - |
dc.relation | J. Clin. Oncol., 33(15), | - |
dc.relation.ispartof | J. Clin. Oncol. | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | TIGER-3: A phase 3, open-label, randomized study of rociletinib vs cytotoxic chemotherapy in patients (pts) with mutant EGFR non-small cell lung cancer (NSCLC) progressing on prior EGFR TKI therapy and doublet chemotherapy. | - |
dc.relation.pages | - | - |
dc.relation.journalvolume | 33 | - |
dc.relation.journalissue | 15 | - |
item.grantfulltext | none | - |
item.fulltext | no fulltext | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。